September 21st, 2014
Antibiotic Recall Due to Particulate Matter
Antibiotic Recall Due to Particulate Matter
August 20, 2014
On Wednesday, the U.S. Food and Drug Administration reported that Cubist Pharmaceuticals is issuing its second recall of Cubicin (daptomycin injection) due to complaints of particulates found in vials.
The particulates were found in nine lots that were distributed between July and December 2013. If in possession of one of these lots, contact the company directly at (855) 534-8309.
This is the second recall in August alone of the drug used to treat skin and blood infections.
A spokeswoman for the drug manufacturer told FDANews that none of the particulate matter found seems to be glass and that they don’t suspect that a manufacturing problem is the cause.
No adverse events have been reported.
References:
1. Freund L. Another nine lots of Cubicin recalled by Cubist. FDANews. 2014 Aug 20.
2. Reuters. Cubist Pharma recalls some vials of antibiotic Cubicin. Pharmacy Learning Network. 2014 Aug 6.
RELATED ARTICLES
Baxter Recalls Potassium Chloride Injection
Heparin Recall Due to Human Hair
Warfarin Sodium Tablets Recall
FDA Issues Reminder to Avoid Products from Texas Compounder
Compounding Pharmacy Recall
- August 14th, 2015
Diagnosing Headache: Patient, Provider Communication is KeyRead - September 7th, 2012
Hopes dashed for ginkgo biloba in Alzheimer’s disease Read - February 22nd, 2014
Lilly's Ramucirumab for Lung Cancer Improves Survival in Late-Stage TrialRead - September 30th, 2012
Xanax and Valium Boost Dementia Risk by 50 PercentRead - August 30th, 2012
Smoking Cessation Lowers Risk of Brain BleedRead
Geriatric Nutrition
Without good nutrition, positive drug therapy outcomes are very difficult to obtain, For the best in Geriatric Nutritional Information
Find out more Optima SolutionsContinuing Education
Each month we will post an analysis of specific aspects of government long-term healthcare regulations.
Find out moreHealth care alerts
Video
